Orakl Oncology combines data and biology to bring new drugs to cancer patients
TechCrunch Startup News · TechCrunch
December 4, 20243m 38s
Audio is streamed directly from the publisher (mgln.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Cancer incidence is on the rise, particularly among younger adults, but most new drug compounds fail to progress through clinical trials. According to French entrepreneur Fanny Jaulin (on the right in the picture above), the problem lies with clinical trial design.
Learn more about your ad choices. Visit podcastchoices.com/adchoices